Loading...
Loading...
Encore Medical, Inc.
Encore Medical, Inc.. Spoken Alpha tracks EMI's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks EMI's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for EMI.
curl https://api.spokenalpha.com/v1/companies/EMI| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.36 | $3.59 | -6.3% | +0.7% | -2.0% |
| Q4 FY2026 | $3.01 | $3.72 | -19.0% | +2.9% | +4.6% |
| Q3 FY2026 | $3.38 | $3.60 | -6.0% | -3.2% | -3.9% |
| Q2 FY2026 | $3.05 | $3.75 | -18.8% | +0.5% | +1.8% |
| Q1 FY2025 | $3.32 | $3.61 | -8.0% | -2.5% | -4.3% |
| Q4 FY2025 | $3.49 | $3.84 | -9.1% | +1.8% | +4.6% |
| Q3 FY2025 | $3.33 | $3.81 | -12.7% | +1.5% | +2.3% |
| Q2 FY2025 | $3.31 | $3.72 | -11.1% | +1.8% | -0.6% |
| Q1 FY2024 | $3.14 | $3.70 | -15.2% | -0.1% | 0.0% |
| Q4 FY2024 | $3.35 | $3.89 | -13.8% | -3.4% | -3.9% |